Correvio Reports Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
Correvio Pharma (CORV) Misses Q3 EPS by 6c, Revenues Miss
November 14, 2019 7:03 AM ESTCorrevio Pharma (NASDAQ: CORV) reported Q3 EPS of ($0.23), $0.06 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $6.67 million versus the consensus estimate of $8.82 million.
"On the commercial front, our marketed products portfolio has generated $21.3 million year-to-date in 2019, with $6.7... More
